Return to search

BAS Medical Raises $20 Million

BAS Medical Inc., a San Mateo, Calif.-based developer of clinical applications for a peptide hormone called relaxin, has raised $20 million in Series C funding, according to VentureWire. Return backers include Domain Associates, Kleiner Perkins Caufield & Byers and Sears Capital Management Inc. It has now raised a total of $40 million.